FC
Showing 1 - 25 of 3,559
Severe Hemophilia A Trial in Iran, Islamic Republic of (Factor VIII, recombinant human with Fc fusion (rFVIII-Fc))
Completed
- Severe Hemophilia A
- Factor VIII, recombinant human with Fc fusion (rFVIII-Fc)
-
Isfahan, Iran, Islamic Republic of
- +4 more
Nov 13, 2023
Ulcerative Colitis, Histology Remission, Fecal Calprotetin Trial in Jinan (FIT + FC)
Recruiting
- Ulcerative Colitis
- +4 more
- FIT + FC
-
Jinan, Shandong, ChinaQilu hospital of Shandong University
Nov 14, 2022
Esophageal Tumors, Dysphagia Trial in São Paulo (Fully Covered Esophageal Prosthesis (FC-SEMS), Partially Covered Esophageal
Recruiting
- Esophageal Neoplasms
- Dysphagia
- Fully Covered Esophageal Prosthesis (FC-SEMS)
- Partially Covered Esophageal Prosthesis (PC-SEMS)
-
São Paulo, BrazilInstituto do Câncer do Estado de São Paulo
Oct 4, 2023
Natural Killer T Cells ExpressingInvariant T Receptor :
Not yet recruiting
- Systemic Lupus Erythematosus
- Physiopathology
- Blood sample
-
Tours, FranceUniversity Hospital
May 12, 2023
A Prospective and Retrospective Interventional Study on
Recruiting
- Severe Hemophilia A Without Inhibitor
- serum biomarker.
-
Taipei, Neihu Dist., TaiwanTri-Service General Hospital Hemophilia Care Center
Aug 10, 2023
LYNPARZA Pancreas Cancer Japan Post-Marketing Surveillance (PMS)
Recruiting
- Pancreatic Neoplasms
-
Osaka, Lyn010001, Japan
- +46 more
Aug 4, 2022
Advanced Solid Tumor, Refractory Non-Hodgkin Lymphoma Trial (HCB101)
Not yet recruiting
- Advanced Solid Tumor
- Refractory Non-Hodgkin Lymphoma
- (no location specified)
May 28, 2023
Women Undergoing Fertility Treatments Trial (PulseNmore FC)
Not yet recruiting
- Women Undergoing Fertility Treatments
- PulseNmore FC
- (no location specified)
Aug 2, 2022
Functional Constipation Trial (Probiotic, Placebo)
Not yet recruiting
- Functional Constipation
- Probiotic
- Placebo
- (no location specified)
Oct 9, 2023
Health Volunteer Trial in Beijing (Recombinant human CTLA-4-FC fusion protein for injection 1mg/kg, Recombinant human CTLA-4-FC
Recruiting
- Health Volunteer
- Recombinant human CTLA-4-FC fusion protein for injection 1mg/kg
- +9 more
-
Beijing, ChinaPeking University People's Hospital
Feb 15, 2022
Advanced Malignant Solid Tumor Trial in Sacramento (CD24 Extracellular Domain-IgG1 Fc Domain Recombinant Fusion Protein CD24Fc,
Terminated
- Advanced Malignant Solid Neoplasm
- CD24 Extracellular Domain-IgG1 Fc Domain Recombinant Fusion Protein CD24Fc
- Placebo Administration
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Mar 8, 2022
Hematopoietic Stem Cell Transplantation, Acute GVHD, Acute Myeloid Leukemia Trial in United States (CD24Fc, Placebo,
Terminated
- Hematopoietic Stem Cell Transplantation
- +4 more
- CD24Fc
- +3 more
-
Duarte, California
- +3 more
Oct 18, 2022
Hemostasis Trial in Atlanta (Fibrinogen Concentrate (FC), Cryoprecipitate)
Completed
- Hemostasis
- Fibrinogen Concentrate (FC)
- Cryoprecipitate
-
Atlanta, GeorgiaChildren's Healthcare of Atlanta (CHOA), Egleston
Mar 14, 2022
Acute Gout Trial in Nanchang (rhTNFR-Fc, Triamcinolone Acetonide)
Not yet recruiting
- Acute Gout
- rhTNFR-Fc
- Triamcinolone Acetonide
-
Nanchang, Jiangxi, ChinaDepartment of Rheumatology and Clinical Immunology, Jiangxi Prov
Jun 28, 2023
Pulmonary Arterial Hypertension Trial (Sotatercept)
Not yet recruiting
- Pulmonary Arterial Hypertension
- Sotatercept
- (no location specified)
Apr 5, 2023
Pregnancy Prevention Trial in Durban (FC2 Condom, Cupid Condom, Cupid 2 Condom)
Completed
- Pregnancy Prevention
- FC2 Condom
- +2 more
-
Durban, Kwa-Zulu Natal, South AfricaMatCH Research Unit [Maternal, Adolescent and Child Health Resea
Jan 18, 2022
Healthy Trial in Shanghai (SI-F019)
Completed
- Healthy
-
Shanghai, Shanghai, ChinaShanghai Public Health Clinical Center Ethics Committee Approval
Dec 11, 2022
Long-term Treatment With YISAIPU for Fujian RA Patients
Recruiting
- Rheumatoid Arthritis
- YISAIPU® ( An etanercept biosimilar)
- csDMARDs
-
Xiamen, Fujian, ChinaThe First Affiliated Hospital of Xiamen University
Jun 15, 2022
Solid Tumor, Classic Hodgkin Lymphoma Trial in China (IMM01, Tislelizumab)
Recruiting
- Solid Tumor
- Classic Hodgkin Lymphoma
-
Hangzhou, China
- +4 more
Apr 18, 2023
Metastatic Prostate Cancer Trial in Baltimore ([18F]FLOR (FC303) Injection)
Recruiting
- Metastatic Prostate Cancer
- [18F]FLOR (FC303) Injection
-
Baltimore, MarylandJohns Hopkins University
Dec 14, 2021
Chemo-induced Thrombocytopenia Trial in Shanghai (QL0911)
Completed
- Chemotherapy-induced Thrombocytopenia
-
Shanghai, Shanghai, ChinaShanghai East Hospital
May 5, 2023